Table 1.
Clinical characteristics of patients involved in the study.
| Characteristics | Training cohort (TCGA-UVM, n = 80) | Validation cohort (GSE22138, n = 63) |
|---|---|---|
| Age at diagnosis, years | ||
| <60 | 36 (45.00%) | 28 (44.44%) |
| ≥60 | 44 (55.00%) | 35 (55.56%) |
| Unknown | 0 (0.00%) | 0 (0.00%) |
| Gender | ||
| Female | 35 (43.75%) | 24 (38.10%) |
| Male | 45 (56.25%) | 39 (61.90%) |
| Unknown | 0 (0.00%) | 0 (0.00%) |
| Stage | ||
| I | 0 (0.00%) | NA |
| II | 36 (45.00%) | NA |
| III | 40 (50.00%) | NA |
| IV | 4 (5.00%) | NA |
| Unknown | 0 (0.00%) | NA |
| T classification | ||
| T1 | 0 (0.00%) | NA |
| T2 | 4 (5.00%) | NA |
| T3 | 36 (45.00%) | NA |
| T4 | 38 (47.50%) | NA |
| Unknown | 2 (2.50%) | NA |
| N classification | ||
| N0 | 76 (95.00%) | NA |
| N1 | 0 (0.00%) | NA |
| Unknown | 4 (5.00%) | NA |
| M classification | ||
| M0 | 73 (91.25%) | 28 (44.44%) |
| M1 | 3 (3.75%) | 35 (55.56%) |
| Unknown | 4 (5.00%) | 0 (0.00%) |
| Extrascleral extension | ||
| No | 68 (85.00%) | 48 (76.19%) |
| Yes | 7 (8.75%) | 5 (7.94%) |
| Unknown | 5 (6.25%) | 10 (15.87%) |
| Tumor basal diameter, mm | ||
| <12 | 6 (7.50%) | 11 (17.46%) |
| ≥12 | 73 (91.25%) | 42 (66.67%) |
| Unknown | 1 (1.25%) | 10 (15.87%) |
| Tumor thickness | ||
| <8 | 15 (18.75%) | 3 (4.76%) |
| ≥8 | 65 (81.25%) | 60 (95.24%) |
| Unknown | 0 (0.00%) | 0 (0.00%) |
| Tumor side | ||
| Right | NA | 30 (47.62%) |
| Left | NA | 33 (52.38%) |
| Unknown | NA | 0 (0.00%) |
| Tumor location | ||
| On equator | NA | 42 (66.67%) |
| Anterior to equator | NA | 3 (4.76%) |
| Posterior to equator | NA | 9 (14.29%) |
| Other | NA | 4 (6.35%) |
| Unknown | NA | 5 (7.94%) |
| Retinal detachment | ||
| No | NA | 22 (34.92%) |
| Yes | NA | 36 (57.14%) |
| Unknown | NA | 5 (7.94%) |